pharma · Primary Sclerosing Cholangitis (PSC) · No medical condition.
Dr. Falk Pharma
Dr. Falk Pharma GmbH
Dr. Falk Pharma clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Leinenweberstraße 5, Freiburg im Breisgau, Baden-Württemberg 79108, DE HQ
399 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Leinenweberstraße 5, Freiburg im Breisgau, Baden-Württemberg 79108, DE
- Employees
- 399
- Programs
- 11
- Drugs
- 15
- Patents
- 0
Dr. Falk Pharma projects
3 ClinicalTrials.gov programs sponsored by Dr. Falk Pharma.
Dr. Falk Pharma has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Dr. Falk Pharma have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.